A detailed history of Two Sigma Investments, LP transactions in Alpine Immune Sciences, Inc. stock. As of the latest transaction made, Two Sigma Investments, LP holds 519,971 shares of ALPN stock, worth $0. This represents 0.05% of its overall portfolio holdings.

Number of Shares
519,971
Previous 378,413 37.41%
Holding current value
$0
Previous $7.21 Million 185.79%
% of portfolio
0.05%
Previous 0.02%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$17.75 - $41.6 $2.51 Million - $5.89 Million
141,558 Added 37.41%
519,971 $20.6 Million
Q4 2023

Feb 14, 2024

BUY
$8.54 - $20.22 $1.6 Million - $3.8 Million
187,824 Added 98.55%
378,413 $7.21 Million
Q3 2023

Nov 14, 2023

BUY
$10.13 - $13.98 $1.34 Million - $1.85 Million
132,561 Added 228.44%
190,589 $2.18 Million
Q2 2023

Aug 14, 2023

BUY
$6.84 - $11.91 $396,911 - $691,113
58,028 New
58,028 $596,000
Q3 2022

Nov 14, 2022

BUY
$6.89 - $9.39 $13,049 - $17,784
1,894 Added 9.46%
21,924 $158,000
Q2 2022

Aug 15, 2022

SELL
$6.71 - $9.52 $185,719 - $263,494
-27,678 Reduced 58.02%
20,030 $170,000
Q1 2022

May 16, 2022

SELL
$6.41 - $13.89 $204,953 - $444,118
-31,974 Reduced 40.13%
47,708 $428,000
Q4 2021

Feb 14, 2022

BUY
$10.41 - $13.95 $421,230 - $564,472
40,464 Added 103.18%
79,682 $1.1 Million
Q3 2021

Nov 15, 2021

BUY
$8.19 - $11.31 $182,669 - $252,258
22,304 Added 131.87%
39,218 $418,000
Q2 2021

Aug 16, 2021

SELL
$8.81 - $15.03 $797,014 - $1.36 Million
-90,467 Reduced 84.25%
16,914 $152,000
Q1 2021

May 17, 2021

SELL
$10.02 - $13.92 $411,441 - $571,583
-41,062 Reduced 27.66%
107,381 $1.14 Million
Q4 2020

Feb 16, 2021

BUY
$7.42 - $15.96 $497,718 - $1.07 Million
67,078 Added 82.44%
148,443 $1.87 Million
Q3 2020

Nov 16, 2020

BUY
$7.15 - $11.5 $21,921 - $35,259
3,066 Added 3.92%
81,365 $715,000
Q2 2020

Aug 14, 2020

BUY
$2.77 - $12.1 $216,888 - $947,417
78,299 New
78,299 $760,000

Others Institutions Holding ALPN

About ALPINE IMMUNE SCIENCES, INC.


  • Ticker ALPN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 44,006,700
  • Description
  • Alpine Immune Sciences, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of protein-based immunotherapies for the treatment of cancer, autoimmune/inflammatory disorders, and other diseases. Its product pipeline includes ALPN-101, an inducible T cell costimulator (ICOS)/cluster of differentiation 28 (CD28...
More about ALPN
Track This Portfolio

Track Two Sigma Investments, LP Portfolio

Follow Two Sigma Investments, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Investments, LP with notifications on news.